Cigna Corp. (CI) Given Consensus Rating of “Buy” by Brokerages
Cigna Corp. (NYSE:CI) has been assigned an average recommendation of “Buy” from the sixteen ratings firms that are currently covering the company. Six equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $157.00.
A number of equities analysts recently weighed in on CI shares. Goldman Sachs Group Inc. reaffirmed a “buy” rating and issued a $160.00 price target on shares of Cigna Corp. in a report on Thursday, September 8th. Leerink Swann reduced their price target on Cigna Corp. from $160.00 to $155.00 and set an “outperform” rating for the company in a report on Monday, August 1st. Zacks Investment Research raised Cigna Corp. from a “sell” rating to a “hold” rating in a report on Tuesday, October 4th. William Blair reaffirmed a “buy” rating on shares of Cigna Corp. in a report on Wednesday, August 31st. Finally, Jefferies Group reissued a “buy” rating on shares of Cigna Corp. in a report on Tuesday, August 23rd.
Shares of Cigna Corp. (NYSE:CI) opened at 138.70 on Monday. The company has a market capitalization of $35.61 billion, a price-to-earnings ratio of 18.85 and a beta of 0.50. Cigna Corp. has a 52 week low of $115.03 and a 52 week high of $148.99. The company’s 50 day moving average price is $125.59 and its 200-day moving average price is $129.17.
Cigna Corp. (NYSE:CI) last released its quarterly earnings results on Thursday, November 3rd. The company reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.91 by $0.03. The company earned $9.90 billion during the quarter, compared to analysts’ expectations of $4.37 billion. Cigna Corp. had a return on equity of 16.17% and a net margin of 4.87%. Cigna Corp.’s quarterly revenue was up 5.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.28 EPS. Analysts anticipate that Cigna Corp. will post $7.98 earnings per share for the current fiscal year.
In related news, insider Jason D. Sadler sold 4,000 shares of the stock in a transaction that occurred on Monday, October 31st. The stock was sold at an average price of $121.80, for a total value of $487,200.00. Following the completion of the transaction, the insider now directly owns 34,019 shares in the company, valued at $4,143,514.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP John M. Murabito sold 58,822 shares of the stock in a transaction that occurred on Monday, November 7th. The stock was sold at an average price of $125.09, for a total value of $7,358,043.98. Following the completion of the transaction, the executive vice president now owns 115,109 shares of the company’s stock, valued at $14,398,984.81. The disclosure for this sale can be found here. 1.20% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently modified their holdings of the company. Acrospire Investment Management LLC raised its position in shares of Cigna Corp. by 166.7% in the second quarter. Acrospire Investment Management LLC now owns 800 shares of the company’s stock valued at $102,000 after buying an additional 500 shares during the last quarter. Live Your Vision LLC acquired a new position in shares of Cigna Corp. during the third quarter valued at $113,000. Invictus RG raised its position in shares of Cigna Corp. by 1,056.8% in the second quarter. Invictus RG now owns 1,018 shares of the company’s stock valued at $130,000 after buying an additional 930 shares during the last quarter. M&R Capital Management Inc. acquired a new position in shares of Cigna Corp. during the second quarter valued at $153,000. Finally, SRB Corp raised its position in shares of Cigna Corp. by 5.8% in the third quarter. SRB Corp now owns 1,181 shares of the company’s stock valued at $154,000 after buying an additional 65 shares during the last quarter. Institutional investors own 85.84% of the company’s stock.
Cigna Corp. Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.
Receive News & Stock Ratings for Cigna Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corp. and related stocks with our FREE daily email newsletter.